HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A differential impact of lithium on endothelium-dependent but not on endothelium-independent vessel relaxation.

Abstract
Lithium is drug for bipolar disorders with a narrow therapeutic window. Lithium was recently reported to prevent stroke and protect vascular endothelium but tends to accumulate particularly in the brain and kidney. Here, adverse effects are common; however mechanisms are still vaguely understood. If lithium could also negatively influence the endothelium is unclear. We hypothesize that at higher lithium levels, the effects on endothelium reverses--that lithium also impairs endothelial-dependent relaxation of blood vessels. Vessel grafts from de-nerved murine aortas and porcine middle cerebral arteries were preconditioned using media supplemented with lithium chloride or acetate (0.4-100 mmol/L). Native or following phenylephrine-induced vasoconstriction, the relaxation capacity of preconditioned vessels was assessed by isometric myography, using acetylcholine to test the endothelium-dependent or sodium nitroprusside to test the endothelium-independent vasorelaxation, respectively. At the 0.4 mmol/L lithium concentration, acetylcholine-induced endothelium-dependent vessel relaxation was slightly increased, however, diminished in a concentration-dependent manner in vessel grafts preconditioned with lithium at higher therapeutic and supratherapeutic concentrations (0.8-100 mmol/L). In contrast, endothelium-independent vasorelaxation remained unaltered in preconditioned vessel grafts at any lithium concentration tested. Lithium elicits opposing effects on endothelial functions representing a differential impact on the endothelium within the narrow therapeutic window. Lithium accumulation or overdose reduces endothelium-dependent but not endothelium-independent vasorelaxation. The differentially modified endothelium-dependent vascular response represents an additional mechanism contributing to therapeutic or adverse effects of lithium.
AuthorsBert Bosche, Marek Molcanyi, Thomas Noll, Soham Rej, Birgit Zatschler, Thorsten R Doeppner, Jürgen Hescheler, Daniel J Müller, R Loch Macdonald, Frauke V Härtel
JournalProgress in neuro-psychopharmacology & biological psychiatry (Prog Neuropsychopharmacol Biol Psychiatry) Vol. 67 Pg. 98-106 (Jun 03 2016) ISSN: 1878-4216 [Electronic] England
PMID26875501 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Chemical References
  • Antimanic Agents
  • Enzyme Inhibitors
  • Macrocyclic Compounds
  • Oxazoles
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • xestospongin D
  • Phenylephrine
  • Nitric Oxide Synthase
  • Lithium Chloride
  • Acetylcholine
Topics
  • Acetylcholine (pharmacology)
  • Animals
  • Antimanic Agents (pharmacology)
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Isometric Contraction (drug effects)
  • Lithium Chloride (pharmacology)
  • Macrocyclic Compounds (pharmacology)
  • Mice
  • Nitric Oxide Synthase (metabolism)
  • Oxazoles (pharmacology)
  • Phenylephrine (pharmacology)
  • Statistics, Nonparametric
  • Swine
  • Time Factors
  • Vasoconstrictor Agents (pharmacology)
  • Vasodilation (drug effects)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: